Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefan Bekiranov
Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy Against Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma
PLoS ONE
Multidisciplinary
Related publications
Androgen Receptor Inhibitor–induced “BRCAness” and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
Oncotarget
Oncology
Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer
Chinese Journal of Cancer
Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancer Journal
Cancer Research
Oncology
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
Inhibition of Hedgehog and Androgen Receptor Signaling Pathways Produced Synergistic Suppression of Castration-Resistant Prostate Cancer Progression
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer
Journal of Urology
Urology
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Androgen-Regulated miR-32 Targets BTG2 and Is Overexpressed in Castration-Resistant Prostate Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology